Silibinin Schiff Base Derivatives Counteract CCl4-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities
Rong Xu,1,* Siyan Qiu,1,* Jie Zhang,1 Xiaoli Liu,1 Ling Zhang,1 Haizhu Xing,1 Min You,1 Man Wang,1 Yuting Lu,1 Peng Zhang,1 Jing Zhu1,2 1Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine...
Main Authors: | Xu R, Qiu S, Zhang J, Liu X, Zhang L, Xing H, You M, Wang M, Lu Y, Zhang P, Zhu J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/silibinin-schiff-base-derivatives-counteract-ccl4-induced-acute-liver--peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Design, Synthesis and Biological Evaluation of Glycosylated Derivatives of Silibinin as Potential Anti-Tumor Agents
by: Xi JJ, et al.
Published: (2023-07-01) -
An Overview on the Effects of Silibinin on Different MicroRNAs Expression in Cancer
by: Vahid Akbari Kordkheyli, et al.
Published: (2018-10-01) -
Silibinin, a potential fasting mimetic, inhibits hepatocellular carcinoma by triggering extrinsic apoptosis
by: Biying Xiao, et al.
Published: (2024-01-01) -
Inhibition of Phagocytosis by Silibinin in Mouse Macrophages
by: Kyung-Hoon Sun, et al.
Published: (2023-10-01) -
A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment
by: Pantha Prodip Ray, et al.
Published: (2024-02-01)